Correlation Between Rezolute and Sino Biopharmaceutica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rezolute and Sino Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and Sino Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rezolute and Sino Biopharmaceutical Limited, you can compare the effects of market volatilities on Rezolute and Sino Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of Sino Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and Sino Biopharmaceutica.

Diversification Opportunities for Rezolute and Sino Biopharmaceutica

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Rezolute and Sino is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and Sino Biopharmaceutical Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sino Biopharmaceutical and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with Sino Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sino Biopharmaceutical has no effect on the direction of Rezolute i.e., Rezolute and Sino Biopharmaceutica go up and down completely randomly.

Pair Corralation between Rezolute and Sino Biopharmaceutica

Given the investment horizon of 90 days Rezolute is expected to under-perform the Sino Biopharmaceutica. In addition to that, Rezolute is 1.19 times more volatile than Sino Biopharmaceutical Limited. It trades about -0.04 of its total potential returns per unit of risk. Sino Biopharmaceutical Limited is currently generating about 0.07 per unit of volatility. If you would invest  38.00  in Sino Biopharmaceutical Limited on September 16, 2024 and sell it today you would earn a total of  4.00  from holding Sino Biopharmaceutical Limited or generate 10.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Rezolute  vs.  Sino Biopharmaceutical Limited

 Performance 
       Timeline  
Rezolute 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rezolute has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's essential indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Sino Biopharmaceutical 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Sino Biopharmaceutical Limited are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Sino Biopharmaceutica may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Rezolute and Sino Biopharmaceutica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rezolute and Sino Biopharmaceutica

The main advantage of trading using opposite Rezolute and Sino Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, Sino Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sino Biopharmaceutica will offset losses from the drop in Sino Biopharmaceutica's long position.
The idea behind Rezolute and Sino Biopharmaceutical Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stocks Directory
Find actively traded stocks across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm